NYSE · Healthcare Plans · USD
UnitedHealth Group Incorporated (UNH) Stock Analysis
UnitedHealth Group Incorporated (UNH) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
UNH Key Statistics
As of Sep 4, 2026Trading
- Open
- $397.05
- Previous Close
- $400.94
- Day's Range
- 395.20–402.23
- 52-Week Range
- 255.97–461.62
- Volume
- 5.57M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.62
Valuation
- Market Cap
- $356.47B
- P/E Ratio
- 25.51
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 17.70
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.09
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.79
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 15.57
Financials (FY)
- Revenue (FY)
- $447.57B+11.81%
- Net Income (FY)
- $12.06B−16.31%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 3.14%
- Shares Outstanding
- 897.59M
- 1-Year Return
- +31.38%
Dividend and dates
- Dividend
- $9.28+2.34%
- Ex-Dividend Date
- September 14, 2026
- Earnings Date
- October 27, 2026estimated
- Avg Volume
- 5.35M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
UNH Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +21.93% |
| 2025 | −33.14% |
| 2024 | −2.41% |
| 2023 | +0.80% |
| 2022 | +6.94% |
| 2021 | +45.20% |
| 2020 | +21.25% |
| 2019 | +20.00% |
| 2018 | +14.52% |
| 2017 | +39.83% |
| 2016 (partial year) | +13.57% |
As of September 4, 2026.
UNH Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $447.57B | $12.06B | 2.7% |
| 2024 | $400.28B | $14.41B | 3.6% |
| 2023 | $371.62B | $22.38B | 6.0% |
| 2022 | $324.16B | $20.12B | 6.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $447.57B | $82.92B | $18.96B | $12.06B | 2.7% |
| 2024 | $400.28B | $89.40B | $32.29B | $14.41B | 3.6% |
| 2023 | $371.62B | $90.96B | $32.36B | $22.38B | 6.0% |
| 2022 | $324.16B | $79.62B | $28.44B | $20.12B | 6.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
UNH Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $4.53 | 2 | — |
| 2025 | $8.73 | 4 | +6.7% |
| 2024 | $8.18 | 4 | +12.2% |
| 2023 | $7.29 | 4 | +13.9% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $4.53 | 2 | — |
| 2025 | $8.73 | 4 | +6.7% |
| 2024 | $8.18 | 4 | +12.2% |
| 2023 | $7.29 | 4 | +13.9% |
| 2022 | $6.40 | 4 | +14.3% |
| 2021 | $5.60 | 4 | +15.9% |
| 2020 | $4.83 | 4 | +16.7% |
| 2019 | $4.14 | 4 | +20.0% |
| 2018 | $3.45 | 4 | +20.0% |
| 2017 | $2.88 | 4 | +130.0% |
| 2016 | $1.25 | 2 | — |
Most recent payment: $2.27 per share, ex-dividend June 15, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
UNH Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | UNH | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 25.51 | 25.66 | 1% below |
| P/S ratio | 0.79 | 0.44 | 80% above |
| Profit margin | 3.14% | 1.18% | 2.0 pts above |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
2 Reasons to Like UNH and 1 to Stay Skeptical
YahooUnitedHealth Falls as 30% of Approval Barriers Vanish
YahooUnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
YahooUnitedHealth’s Earnings Beat And Cost Controls Could Be A Game Changer For UnitedHealth Group (UNH)
YahooUnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?
YahooUnitedHealth Stock Recovered Before Its Margins Did
Yahoo
All 20 articles ↓Show fewer ↑
Is UnitedHealth Finally Turning the Corner After a Tough 2025?
YahooIs UnitedHealth Group (UNH) Finally Turning the Corner Under Stephen Hemsley?
YahooHow Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
YahooUnitedHealth’s Policy Change Opens a New Chapter for its Insurance Business
YahooHow many employees does UnitedHealth have in 2026? Locations & layoffs explained
YahooUnitedHealth Rises as 30% of Prior Approvals Head for Removal
YahooUnitedHealth (UNH) Stock May Look Reasonable Despite IRS Tax Scrutiny
YahooBrokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet
YahooUnitedHealth Stock Rallies as Insurer Targets Prior-Authorization Removal for 30% of Services
YahooUNH Stock Gets Cheaper Only If The Margins Come Back
YahooCVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
YahooHow Is UnitedHealth Group's Stock Performance Compared to Other Healthcare Plan Stocks?
YahooAM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries
YahooUnitedHealth Group (UNH) As Tepper Exits, Fair Value Stays In Focus
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Healthcare Plans Stocks
CVS Health Corporation
$123.73B
ELVElevance Health, Inc.
$88.37B
CIThe Cigna Group
$74.65B
HUMHumana Inc.
$48.22B
CNCCentene Corporation
$33.12B
MOHMolina Healthcare, Inc.
$10.48B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
NVSNovartis AG
$304.10B













